Risks of Opioids in ST-Elevation Myocardial Infarction: A Review
- PMID: 30155802
- DOI: 10.1007/s40264-018-0710-y
Risks of Opioids in ST-Elevation Myocardial Infarction: A Review
Abstract
Although opioids are recommended and frequently used in the acute phase of ST-elevation myocardial infarction (STEMI), their use is accompanied by serious side effects. In particular, gastrointestinal adverse effects may disturb absorption of essential oral medication like platelet inhibitors. This may cause suboptimal platelet inhibition and increased risk of acute stent thrombosis. Some clinical studies have already demonstrated these negative results. Alternative strategies to optimize platelet inhibition and pain relief in STEMI are being investigated. Clinicians should become more aware of the potential side effects of opioids in STEMI.
Similar articles
-
Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme.Eur Heart J. 2016 Apr 1;37(13):1063-71. doi: 10.1093/eurheartj/ehv567. Epub 2015 Nov 17. Eur Heart J. 2016. PMID: 26578201
-
Opioids and ST Elevation Myocardial Infarction: A Systematic Review.Heart Lung Circ. 2019 May;28(5):697-706. doi: 10.1016/j.hlc.2018.12.015. Epub 2019 Feb 1. Heart Lung Circ. 2019. PMID: 30745015
-
Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.Thromb Haemost. 2017 Jan 5;117(1):99-104. doi: 10.1160/TH16-07-0569. Epub 2016 Oct 13. Thromb Haemost. 2017. PMID: 27734075
-
Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression.Neuropharmacology. 2018 Mar 15;131:238-255. doi: 10.1016/j.neuropharm.2017.12.032. Epub 2017 Dec 20. Neuropharmacology. 2018. PMID: 29273520 Review.
-
Anticipating and managing opioid side effects in the elderly.Consult Pharm. 2013 Mar;28(3):150-9. doi: 10.4140/TCP.n.2013.150. Consult Pharm. 2013. PMID: 23462024 Review.
Cited by
-
Outcomes of ST-Elevation Myocardial Infarction in Patients With Opioid Dependence: A National Inpatient Sample Study.Cureus. 2024 Jul 9;16(7):e64161. doi: 10.7759/cureus.64161. eCollection 2024 Jul. Cureus. 2024. PMID: 39119443 Free PMC article.
-
Integrated Multichip Analysis and WGCNA Identify Potential Diagnostic Markers in the Pathogenesis of ST-Elevation Myocardial Infarction.Contrast Media Mol Imaging. 2022 Apr 7;2022:7343412. doi: 10.1155/2022/7343412. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35475279 Free PMC article.
-
Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury (Review).Int J Mol Med. 2021 Feb;47(2):485-499. doi: 10.3892/ijmm.2020.4823. Epub 2020 Dec 16. Int J Mol Med. 2021. PMID: 33416090 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources